Clinical trials in Boadilla Del Monte – page 113

3 267 clinical trials in Boadilla Del Monte, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SpainEnsayosClinicos.es

Boadilla Del Monte at a glance

3 267

clinical trials

Research sites1

Quick filters

3 267 trials in Boadilla Del Monte

Open in trial search

Abdominal infection+5

Not yet recruiting

Study on Aztreonam, Avibactam, and Metronidazole for Treating Infections in Neonates and Infants Under 9 Months with Gram-Negative Bacterial Infections

Registered drugNo placebo

Study on Aztreonam, Avibactam, and Metronidazole for Treating Infections in Neonates and Infants Under 9 Months with Gram-Negative Bacterial Infections

Registered drugNo placebo

Spain

Participants:0–17 years
Substances:Avibactam Sodium
Sponsor:Pfizer Inc.

Contact Research Centre

Gastrointestinal stromal tumour

Not yet recruiting

Study of DCC-3116 and ripretinib combination therapy in patients with advanced gastrointestinal stromal tumor (GIST)

Registered drugNo placebo

Study of DCC-3116 and ripretinib combination therapy in patients with advanced gastrointestinal stromal tumor (GIST)

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:DCC-3116
Sponsor:Deciphera Pharmaceuticals Inc.

Contact Research Centre

Secondary progressive multiple sclerosis+1

Not yet recruiting

Study on the Safety and Effects of YTB323 and Drug Combination in Patients with Progressive Multiple Sclerosis

Registered drugNo placebo

Study on the Safety and Effects of YTB323 and Drug Combination in Patients with Progressive Multiple Sclerosis

Registered drugNo placebo

Spain

Participants:18–64 years
Substances:Cyclophosphamide
Sponsor:Novartis Pharma AG

Contact Research Centre

Study of IOMX-0675 alone or combined with pembrolizumab for patients with previously treated advanced or metastatic solid tumors

Not yet recruiting

Registered drugNo placebo

Study of IOMX-0675 alone or combined with pembrolizumab for patients with previously treated advanced or metastatic solid tumors

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:IOMX-0675
Sponsor:iOmx Therapeutics AG

Contact Research Centre

Colorectal cancer

Not yet recruiting

Study of 5-Fluorouracil, Panitumumab, and Sotorasib for Patients with Advanced KRAS G12C Mutated Colorectal Cancer Not Eligible for Standard Chemotherapy

Registered drugNo placebo

Study of 5-Fluorouracil, Panitumumab, and Sotorasib for Patients with Advanced KRAS G12C Mutated Colorectal Cancer Not Eligible for Standard Chemotherapy

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Fluorouracil
Sponsor:Fondation Franc.Cancerologie Digestive

Contact Research Centre

Non-small cell lung cancer stage I

Not yet recruiting

Study on Datopotamab Deruxtecan and Rilvegostomig for Stage I Non-Small Cell Lung Cancer Patients with ctDNA-Positive or High-Risk Features

Registered drugNo placebo

Study on Datopotamab Deruxtecan and Rilvegostomig for Stage I Non-Small Cell Lung Cancer Patients with ctDNA-Positive or High-Risk Features

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Carboplatin
Sponsor:AstraZeneca AB

Contact Research Centre

Acute leukaemia+2

Not yet recruiting

Study Comparing Fosfomycin and Ciprofloxacin for Preventing Fever in Patients with Acute Leukemia After Chemotherapy or Stem Cell Transplant

Registered drugNo placebo

Study Comparing Fosfomycin and Ciprofloxacin for Preventing Fever in Patients with Acute Leukemia After Chemotherapy or Stem Cell Transplant

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Ciprofloxacin
Sponsor:Fundacion Para La Investigacion Y La Innovacion Biosanitaria Del Principado De Asturias

Contact Research Centre

Heart failure with preserved ejection fraction

Not yet recruiting

Study on the Effects of Dapagliflozin for Patients with Heart Failure with Preserved Ejection Fraction

Registered drugNo placebo

Study on the Effects of Dapagliflozin for Patients with Heart Failure with Preserved Ejection Fraction

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Dapagliflozin
Sponsor:Fundacion Para La Investigacion Biomedica Del Hospital Gregorio Maranon

Contact Research Centre

Cardiac operation

Not yet recruiting

Study on the Effects of Inhaled Nitric Oxide on Heart and Lung Function After Cardiac Surgery

Registered drugNo placebo

Study on the Effects of Inhaled Nitric Oxide on Heart and Lung Function After Cardiac Surgery

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Nitric Oxide
Sponsor:Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Princesa

Contact Research Centre

Anal abscess

Not yet recruiting

Study on Amoxicillin and Potassium Clavulanate for Preventing Anal Fistula in Patients After First Perianal Abscess Surgery

Registered drugNo placebo

Study on Amoxicillin and Potassium Clavulanate for Preventing Anal Fistula in Patients After First Perianal Abscess Surgery

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Amoxicillin Trihydrate
Sponsor:MARIANO ARTES CASELLES

Contact Research Centre

Actinic keratosis

Not yet recruiting

Study on the Effectiveness and Safety of Metformin and Methyl Aminolevulinate in Daylight Therapy for Actinic Keratosis Patients

Registered drug

Study on the Effectiveness and Safety of Metformin and Methyl Aminolevulinate in Daylight Therapy for Actinic Keratosis Patients

Registered drug

Spain

Participants:18–64 years · 65+ years
Sponsor:Fundacion Instituto De Investigacion Sanitaria Aragon

Contact Research Centre

Study on Improving Small Bowel Visualization in Capsule Endoscopy for Patients Using Ascorbic Acid, Sodium Ascorbate, Potassium Chloride, and Simeticone

Not yet recruiting

Registered drugNo placebo

Study on Improving Small Bowel Visualization in Capsule Endoscopy for Patients Using Ascorbic Acid, Sodium Ascorbate, Potassium Chloride, and Simeticone

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Ascorbic Acid
Sponsor:Hospital Universitario La Paz

Contact Research Centre

Other cities in Spain

The busiest research cities in the country

All 210 cities in Spain

Clinical research in Boadilla Del Monte

What the registry says about research in the country

01 Infectious Disease Prevention

Clinical trials focusing on vaccine development and immune responses for multiple infectious diseases, including studies of combination vaccines for childhood diseases and COVID-19 boosters.

MMRV Vaccine Studies
COVID-19 Booster Research
RSV Prevention

Special emphasis on pediatric populations and vaccine co-administration safety protocols.

02 Oncology Research

Comprehensive studies on various cancer types, with focus on pediatric liver cancers and innovative treatment approaches for solid tumors.

Hepatoblastoma Treatment
High-Grade Glioma Therapy
Prostate Cancer Management

Integration of targeted therapies and combination treatment protocols.

03 Cardiovascular Medicine

Investigations into cardiovascular disease prevention and treatment, particularly focusing on post-heart attack care and preventive measures.

ASCVD Prevention
Acute Coronary Syndrome
Cardiovascular Risk Management

Emphasis on long-term cardiovascular outcomes and preventive strategies.

04 Women's Health

Studies examining reproductive health and related conditions, including contraceptive efficacy and treatments for gynecological infections.

Contraceptive Development
Vaginal Health Studies
Treatment of Candidiasis

Focus on innovative delivery systems and treatment options.

Back to Spain All countries